Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey J Wigmore

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Cardiothoracic and Vascular Anesthesia|May 18, 2019
20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study)Geoffrey J Wigmore, James R Anstey, Ashley St John, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 21, 2025
The Renal Effect of 20% Human Albumin Solution Fluid Bolus Therapy in Patients After Cardiac Surgery. A Secondary Analysis of the HAS FLAIR II Randomized Clinical TrialGeoffrey J Wigmore, Adam M Deane, Jeffrey J Presneill, et al.
Intensive Care Medicine|July 2, 2024
Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trialGeoffrey J Wigmore, Adam M Deane, Jeffrey J Presneill, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Cardiothoracic and Vascular Anesthesia|May 18, 2019
20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study)Geoffrey J Wigmore, James R Anstey, Ashley St John, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 21, 2025
The Renal Effect of 20% Human Albumin Solution Fluid Bolus Therapy in Patients After Cardiac Surgery. A Secondary Analysis of the HAS FLAIR II Randomized Clinical TrialGeoffrey J Wigmore, Adam M Deane, Jeffrey J Presneill, et al.
Intensive Care Medicine|July 2, 2024
Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trialGeoffrey J Wigmore, Adam M Deane, Jeffrey J Presneill, et al.
Pageof 1